Explore evidence

24,700,000 IU/mLThe median HBV viral load was 2.47 x 10^7 IU/mL.

Camerounhépatite Bpublished 2009HIV MedicineOpenAlexdocument of 5 observations

8.3 %HBV DNA was detected in 14 of the 18 patients with positive or indeterminate HBsAg results, representing 8.3% of the total study population.

Camerounhépatite Bpublished 2009HIV MedicineOpenAlexdocument of 5 observations

0.8 %The proportion of hepatitis B surface antigen-tested patients ranged from 0.8% to 72.5% according to the individual hospital.

Camerounhépatite Bpublished 2020BMC infectious diseaseseurope_pmcdocument of 7 observationsDOI 10.1186/s12879-020-4784-7

5.8 %Two HBV seroprevalence studies in pregnant women were conducted in Cameroon and Zimbabwe, in which a prevalence of 5.8% and 2.7%, respectively, was reported.

Camerounhépatite Bpublished 2024Frontiers in public healthPubMeddocument of 4 observations

9.8 %The prevalence of hepatitis B surface antigen was 9.8% among 552 adult HIV-infected, ART-treated patients in Yaoundé, Cameroon.

Camerounhépatite Bobserved 2006-2007published 2012Antiviral therapyeurope_pmcdocument of 4 observations

26 %Overall, 26% of hepatitis B seropositive patients had an HBV DNA level greater than 40 IU/ml.

Camerounhépatite Bobserved 2006-2007published 2012Antiviral therapyeurope_pmcdocument of 4 observations

24,700,000 IU/mLIn coinfected patients, the median HBV viral load was 2.47 x 10^7 IU/mL.

Camerounhépatite Bpublished 2010BMC Public HealthOpenAlexdocument of 6 observationsDOI 10.1186/1471-2458-10-105

0.8 %The proportion of HBV-tested patients ranged from 0.8% to 72.5% according to the individual hospital.

Camerounhépatite Bpublished 2020BMC Infectious DiseasesOpenAlexdocument of 7 observationsDOI 10.1186/s12879-020-4784-7

6,400,000 inhabitantsWHO reports that 6.4 million children under 5 years live with chronic hepatitis B infection worldwide.

Camerounhépatite Bpublished 2024Frontiers in public healthPubMeddocument of 4 observations

No patient was co-infected with HBV and HCV.

Camerounhépatite B · hépatite Cpublished 2009HIV MedicineOpenAlexdocument of 5 observations

90 %If the HBV infection is acquired at infancy, it may lead to chronic hepatitis B in 90% of the cases.

Camerounhépatite Bpublished 2024Frontiers in public healthPubMeddocument of 4 observations

72.6 %Of 157 coinfected patients, 114 (72.6%) had a HBV viral load < 10 IU/mL.

Camerounhépatite B · VIH/sidapublished 2020BMC Infectious DiseasesOpenAlexdocument of 7 observationsDOI 10.1186/s12879-020-4784-7

9.3 %Of 159 HBsAg-positive patients at the time of the study (9.3%), only 97 (61.0%) received Tenofovir + Lamivudine (or Emtricitabine).

Camerounhépatite Bpublished 2020BMC Infectious DiseasesOpenAlexdocument of 7 observationsDOI 10.1186/s12879-020-4784-7

21 %Among 169 HIV-1-infected patients in Cameroon, 21% were coinfected with hepatitis B virus (HBV) or hepatitis C virus (HCV).

Camerounhépatite B · hépatite C · VIH/sidapublished 2010BMC Public HealthOpenAlexdocument of 6 observationsDOI 10.1186/1471-2458-10-105

2 foldThe risk of hepatotoxicity was 2-fold higher in coinfected patients compared to monoinfected patients.

Camerounhépatite B · hépatite C · VIH/sidapublished 2010BMC Public HealthOpenAlexdocument of 6 observationsDOI 10.1186/1471-2458-10-105

1.6 odds_ratioThe summary odds ratio between non-autoimmune diabetes and HBV infection risk was 1.6 (95% CI: 1.2–2.13) based on 27 studies.

Camerounhépatite B · non-autoimmune diabetes mellituspublished 2021Scientific reportseurope_pmcdocument of 11 observationsDOI 10.1038/s41598-021-88598-6

2.31 hazard_ratioHIV-positive patients with hepatitis B co-infection had a hazard ratio of 2.31 for early antiretroviral treatment initiation.

Camerounhépatite B · VIH/sidaobserved 2014published 2020Health Policy and PlanningOpenAlexdocument of 6 observationsDOI 10.1093/heapol/czaa153